Abstract
A software-driven device for bolus-triggered start of helical computed tomography (CT) was evaluated in liver studies of 30 patients with suspected metastatic liver disease. Compared with results in a control group of 30 patients who underwent conventional contrast material-enhanced helical CT, the study group had significantly higher and more constant parenchymal enhancement (P < .05, Mann-Whitney U test). This technique helps optimize findings at contrast-enhanced helical CT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
